Kang, S., Zhao, S., Wang, X., Pan, Z. (2025). Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China. PLoS ONE. https://doi.org/10.1371/journal.pone.0328730